Summit Financial LLC boosted its holdings in The Clorox Company (NYSE:CLX – Free Report) by 6.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,878 shares of the company’s stock after acquiring an additional 236 shares during the quarter. Summit Financial LLC’s holdings in Clorox were worth $630,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently bought and sold shares of CLX. Brooklyn Investment Group boosted its holdings in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares in the last quarter. Continuum Advisory LLC grew its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares during the last quarter. Millstone Evans Group LLC purchased a new position in shares of Clorox in the fourth quarter valued at $31,000. Asset Planning Inc acquired a new position in shares of Clorox during the 4th quarter worth $32,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new stake in shares of Clorox in the 4th quarter worth about $36,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on CLX. DA Davidson cut their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Barclays cut their price objective on Clorox from $140.00 to $139.00 and set an “underweight” rating for the company in a research report on Thursday, March 27th. Wells Fargo & Company lowered their target price on Clorox from $161.00 to $155.00 and set an “equal weight” rating on the stock in a report on Wednesday. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, JPMorgan Chase & Co. increased their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $159.00.
Clorox Stock Performance
NYSE:CLX opened at $147.77 on Thursday. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The firm’s 50 day moving average is $150.61 and its two-hundred day moving average is $158.66. The company has a market cap of $18.20 billion, a P/E ratio of 40.37, a P/E/G ratio of 2.62 and a beta of 0.45. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the company posted $2.16 EPS. Analysts expect that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.30%. Clorox’s dividend payout ratio (DPR) is 133.33%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- High Flyers: 3 Natural Gas Stocks for March 2022
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Why Are Stock Sectors Important to Successful Investing?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Energy and Oil Stocks Explained
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.